Stay updated on Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Revision: v3.4.2 and removed the previous funding/operating status notice (Revision: v3.4.1).SummaryDifference0.4%

- Check61 days agoChange DetectedA site-wide funding notice was added and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check69 days agoChange DetectedShow glossary is now available, and the page includes updated metadata such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' along with 'No FEAR Act Data', replacing the previous entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check83 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed on the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.